Vincent Diebolt1, Yannick Pletan. 1. GIP CeNGEPS, Direction Générale, Hospices Civils de Lyon, 3 quai des Célestins, Lyon Cedex 02, France. v.diebolt@cengeps.fr
Abstract
UNLABELLED: The general objective of this study was to proceed an inventory of measures which could help to improve the efficiency of clinical research in France. METHOD: Thanks to the discussion between the members of the round-table conference (composed of medical doctors (MD)/investigators; hospital managers; representatives of industrial promoters; general practitioners...), we have looked over the difficulties that meets clinical research in France nowadays. RESULTS: We identified four fields of action: 1) availability of resources for carrying out the trials in time and in quality; 2) feasibility of the clinical trials, in their design and for the recruitment which depends on both of the investigation centers and patients (what is the image of human testing in the society?); 3) skills and motivation of all the elements of staffs in charge of clinical trials (MD; nurses; and the new jobs in medical research); 4) promptness and efficiency of the administrative organisation for a fast starting up of the trials. CONCLUSION: This study, which doesn't pretend to sufficiency, shows the gap of improvement for French clinical trials organisation.
UNLABELLED: The general objective of this study was to proceed an inventory of measures which could help to improve the efficiency of clinical research in France. METHOD: Thanks to the discussion between the members of the round-table conference (composed of medical doctors (MD)/investigators; hospital managers; representatives of industrial promoters; general practitioners...), we have looked over the difficulties that meets clinical research in France nowadays. RESULTS: We identified four fields of action: 1) availability of resources for carrying out the trials in time and in quality; 2) feasibility of the clinical trials, in their design and for the recruitment which depends on both of the investigation centers and patients (what is the image of human testing in the society?); 3) skills and motivation of all the elements of staffs in charge of clinical trials (MD; nurses; and the new jobs in medical research); 4) promptness and efficiency of the administrative organisation for a fast starting up of the trials. CONCLUSION: This study, which doesn't pretend to sufficiency, shows the gap of improvement for French clinical trials organisation.